PRICE T ROWE ASSOCIATES INC /MD/ - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 43 filers reported holding AIM IMMUNOTECH INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q1 2023$9
-75.0%
20,300
-82.5%
0.00%
Q4 2022$36
-99.9%
115,7000.0%0.00%
Q3 2022$68,000
-25.3%
115,700
-0.9%
0.00%
Q2 2022$91,000
-26.6%
116,8000.0%0.00%
Q1 2022$124,000
+15.9%
116,8000.0%0.00%
Q4 2021$107,000
-54.7%
116,8000.0%0.00%
Q3 2021$236,000
-6.0%
116,8000.0%0.00%
Q2 2021$251,000
-5.3%
116,8000.0%0.00%
Q1 2021$265,000
+26.8%
116,8000.0%0.00%
Q4 2020$209,000
-16.7%
116,8000.0%0.00%
Q3 2020$251,000116,8000.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q4 2021
NameSharesValueWeighting ↓
XTX MARKETS LLC 11,019$20,0000.04%
Virtu Financial LLC 103,807$186,0000.02%
ACT WEALTH MANAGEMENT, LLC 10,000$18,0000.01%
SeaCrest Wealth Management, LLC 48,873$87,0000.01%
Arkadios Wealth Advisors 20,000$35,0000.01%
Traynor Capital Management, Inc. 14,777$26,0000.01%
GSA CAPITAL PARTNERS LLP 17,047$31,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 111,000$199,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 20,200$36,0000.00%
Tower Research Capital LLC (TRC) 12,513$22,0000.00%
View complete list of AIM IMMUNOTECH INC shareholders